EX-10.26 2 dex1026.htm BUSINESS DEVELOPMENT SERVICE AGREEMENT BUSINESS DEVELOPMENT SERVICE AGREEMENT This Agreement is made effective as of January 2, 2011 by and between:Business Development Service Agreement • May 5th, 2020 • California
Contract Type FiledMay 5th, 2020 JurisdictionFabrinet AB, a company organized and existing under the laws of Sweden, with its principal place of business located at Advokatfirma DLA Nordic KB, Box 7315, 10390 Stockholm, Sweden (the “Provider”), and
BUSINESS DEVELOPMENT SERVICE AGREEMENTBusiness Development Service Agreement • December 22nd, 2014 • Immunoclin Corp • Services-computer processing & data preparation • Nevada
Contract Type FiledDecember 22nd, 2014 Company Industry JurisdictionJAGPAL HOLDINGS INC, a company organized and existing under the laws of Belize, with its principal place of business located at 1 Mapp Street, Belize City, Belize represented by Mr. Amandip Jagpal, acting as President (the “Provider”)
BUSINESS DEVELOPMENT SERVICE AGREEMENTBusiness Development Service Agreement • April 23rd, 2024 • England and Wales
Contract Type FiledApril 23rd, 2024 JurisdictionTHIS BUSINESS DEVELOPMENT SERVICE AGREEMENT (“Agreement”) is made and entered into as of [Insert Effective Date], by and between
BUSINESS DEVELOPMENT SERVICE AGREEMENTBusiness Development Service Agreement • August 29th, 2023 • Metaworks Platforms, Inc. • Services-business services, nec • California
Contract Type FiledAugust 29th, 2023 Company Industry JurisdictionGSD Group, LLC, a company organized and existing under the laws of Arizona, with its principal place of business located at 214 East Roosevelt St., Phoenix, Arizona, 85004 11223 (the “Provider”), and
BUSINESS DEVELOPMENT SERVICE AGREEMENTBusiness Development Service Agreement • December 22nd, 2014 • Immunoclin Corp • Services-computer processing & data preparation • Nevada
Contract Type FiledDecember 22nd, 2014 Company Industry JurisdictionImmunoClin Corporation, a company organized and existing under the laws of the State of Nevada, with its principal place of business located at 1800 Wyoming Avenue, NW, 3rd Floor, Washington, DC 20009 USA, represented by Dr. Dorothy Bray, acting as Director, President and CEO (the “Recipient”)